SAN FRANCISCO, August 06, 2025--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the enrollment of the first participant in ECLIPSE 3. All three trials in the Company’s registrational ...

ECLIPSE is a registrational program to evaluate the safety and efficacy of tobevibart in combination with elebsiran in patients with chronic hepatitis delta (CHD).

All three trials in the Company’s registrational ECLIPSE program for chronic hepatitis delta (CHD) have now been initiated.

ECLIPSE is a registrational program to evaluate the safety and efficacy of tobevibart in combination with elebsiran in patients with chronic hepatitis delta (CHD).

The Minnesota Golden Gophers appear to have their first roster departure of the 2025 season.According to Minnesota’s online roster, Golden Gophers redshirt freshman running backJohann Cardenasis ...

ECLIPSE 2 is one of three trials in Vir Biotechnology’s registrational ECLIPSE program for CHD, which was initiated in March 2025.

Florida Governor Ron DeSantis shared some sharp criticism of the H-1B visa program, even as Trump maintains legal immigration levels.

A Michigan Wolverines transfer running back left the team just a couple of weeks before their first game against New Mexico.